Skip to the content
Aletheia

The Religion with No Name · source record · webpage

Yale Ancient Pharmacology Program (Athanatos Foundation project page)

Athanatos Foundation · 2026

AI-verified citationSRC-ATHANATOS-YAPP
url
https://www.athanatosfoundation.org/yapp/
verification note
Page fetched and read 2026-08-25. The mission language quoted in this case ("reframes our understanding of early Christian ritual and its pharmacological roots"), the goals (systematic ORA, reconstruction of wine-based ritual substances, open phytochemical archive), and the Delphi / Vatican "Pope's Pharmacy" project descriptions verified verbatim. The page does not state that YAPP was the foundation's first grantee; that stronger formulation circulates elsewhere and is not relied on here.
reliability notes
  • The funder's own framing of the research program: the stronger early-Christian goal language appears here, on the funder's page, rather than in Yale's scientific publications.
  • Interest network: Athanatos was founded by Brian Muraresku, the author under examination; the program it supports is also funded by E. Jhong, this project's founder. Disclosed prominently; see SRC-LUKE-KOH-2025.

Evidence drawn from this source

Context· weakTIK-E026

YAPP: institutional capacity aimed at the case's open questions, in the funder's words

what the source states
The Athanatos Foundation's project page describes the Yale Ancient Pharmacology Program as recovering ancient pharmacological knowledge through systematic organic residue analysis, reconstructing "ancient wine-based medicinal and ritual substances," building an open phytochemical archive, confirming "a previously undocumented sanctuary near Delphi and securing access to the Pope's Pharmacy," and states the project "reframes our understanding of early Christian ritual and its pharmacological roots."
what we infer
The measurement capacity this case's decisive tests require is being built — and the strong early-Christian goal language appears on the funder's page rather than in Yale's scientific publications, whose published output (e.g., the Xerxes alabastron opiates work) is conventional archaeochemistry. Program framing is context; only its peer-reviewed results will be evidence.
limitations
  • A funder's self-description. Interest network: Athanatos was founded by the book's author; see TIK-E027 for the funding disclosure naming this project's own founder.